Breaking news FDA panel recommends GSK’s vaccine against RSV Marzo 1, 2023 The Food and Drug Administration’s (FDA) independent advisory panel endorsed on Wednesday GlaxoSmithKline’s respiratory syncytial virus (RSV) vaccine for adults over 60. Ten FDA assessors agr…
